Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze LGND stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate LGND investment potential.

What is LGND stock price today?

Get real-time LGND stock price, historical data, and price charts on Financhill. Track LGND performance with our advanced analysis tools.

Is LGND a good investment?

Evaluate LGND investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy LGND stock?

To buy LGND stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of LGND?

View detailed market capitalization data and company valuation metrics for LGND on our comprehensive analysis page.

What is the P/E ratio of LGND?

Use our fundamental analysis tools to view LGND P/E ratio and compare valuation metrics with industry peers.

What are LGND earnings?

View LGND earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Ligand Pharmaceuticals, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

LGND
Ligand Pharmaceuticals, Inc.

Last Price:

$187.52

Seasonality Move:

16.64%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

Ligand Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 21.5% based on the past 31 years of stock performance.
Ligand Pharmaceuticals, Inc. has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
Is Ligand Pharmaceuticals, Inc. Stock Undervalued?

The current Ligand Pharmaceuticals, Inc. [LGND] share price is $188.50. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Ligand Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 21.5% based on the past 31 years of stock performance.

Ligand Pharmaceuticals, Inc. Stock Rating

Sell

Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Is Ligand Pharmaceuticals, Inc. overpriced?

Ligand Pharmaceuticals, Inc. has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%

Ligand Pharmaceuticals, Inc. Stock Price History

Is LGND stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

ligand.com

52-Week Data

52-Week High:

212.49

52-Week Low:

93.58

Prediction Charts

Market Cap:

3.7B

Price in USD:

188.50

Volume:

194.3K

Beta:

1.45

Technical Analysis

SMA50:

190.59

SMA100:

171.67

SMA200:

140.59

52-Wk Change:

55.81%

Stock Predictions

Is Ligand Pharmaceuticals, Inc. stock public?

Yes, Ligand Pharmaceuticals, Inc. is a publicly traded company.
What is the Ligand Pharmaceuticals, Inc. stock quote today?

The Ligand Pharmaceuticals, Inc. stock price is 188.50 USD today.
How to buy Ligand Pharmaceuticals, Inc. stock online?

You can buy Ligand Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	198.93	201.01	205.32	198.52
Nov-17	201.65	201.29	207.32	200.82
Nov-18	201.77	207.05	208.82	199.00
Nov-19	207.05	206.08	208.05	203.47
Nov-20	209.13	198.96	210.76	198.83
Nov-21	199.49	199.11	204.27	198.90
Nov-24	199.23	206.98	207.03	199.18
Nov-25	207.75	203.52	209.10	202.53
Nov-26	204.52	206.16	207.24	203.23
Nov-28	206.18	203.18	206.67	200.74
Dec-1	199.88	196.97	200.60	192.71
Dec-2	196.97	195.10	201.49	194.21
Dec-3	196.94	193.03	197.00	191.27
Dec-4	192.75	188.50	194.90	187.87

Ligand Pharmaceuticals, Inc. Earnings

Ligand Pharmaceuticals, Inc. Earnings Report: Per Share Ligand Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ligand Pharmaceuticals, Inc. Forecast Revenue Growth

Ligand Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.97 per share, and an increase next year of $0.34 per share.

* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.